Posted in | News

The Recycling Commercialisation Centre Established by WRAP

The Recycling Commercialisation Centre was established by WRAP to support and accelerate the growth and development of early stage technologies in the recycling sector. It is operated by Imperial Innovations – one of the UK’s leading technology commercialisation and investment companies.

Commenting on the contract Steve Creed, Director of Business Growth at WRAP, said:

“WRAP is committed to encouraging growth in the recycling industry through product innovation and developing new markets for recycled materials. A major part of our work is persuading people to think again about whether something is a waste or a resource. Fine-Agg ticks all the boxes and we are delighted that the inventors are working with the Recycling Commercialisation Centre to bring this technology to market."

Successful application of the Fine-Agg technology promises to alleviate disposal of a waste material through the creation of a value-added product. Soil and aggregate washing facilities which produce recycled aggregates typically produce unusable mineral silt and fines as a significant waste material. Waste silt, which can reach up to 10% of the material processed, is commonly disposed of in landfill as it is not perceived as a useful product.

The Recycling Commercialisation Centre will assist in the development of the Fine-Agg technology and help to bring it to market by:

  • providing resources for technical testing and business planning;

  • building a management team;

  • providing access to funds and investor; and

  • developing and exploiting product markets.

Looking to the future co-inventor Dr Cheeseman says of the contract:

“With guidance and support from the Recycling Commercialisation Centre at Imperial Innovations, I am confident that the Fine-Agg technology will have a successful commercial future”.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.